TrialResults-center.org

Menu

Logiparin LMWH
Description Results

LHN-1 - Logiparin

Group by...

in first

in second

in third

All pathologies
venous thrombosis

all type of patients 101 - 8
all type of patients 203 - 77
all type of patients 204 - 72
LWMH 54 - 8

pdf

pathology

Benefit (demonstrated or suggested) and harm

venous thrombosis

All results are NS for efficacy

Trial

control

p<0.05

harm

NS

Siegbahn, 1989

vs twice daily logiparin

Improvement of thrombus size 2.00 [0.68; 5.85]

Mortality NaN [NaN; NaN]

Haemorraghic events NaN [NaN; NaN]

Recurrent thromboembolic events NaN [NaN; NaN]

Trial

Treatments

Patients

Method

Siegbahn, 1989

Once daily logiparin 150 XaI U/kgp, imag (n=10)

vs.

twice daily logiparin 75 XaI U/kg (n=10)

patients with a venographically confirmed episode of DVT

single blind

Parallel groups

Sample size: 10/10

Primary endpoint:

FU duration:

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -